SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending due to a sharp, volatile surge in natural gas prices that has caught many traders off-guard, sparking intense debate among the community. While some speculate this rally is a short squeeze driven by extreme bearish positioning and bullish weather models, others warn that natural gas, known as a 'widow maker,' could quickly reverse, putting significant pressure on KOLD holders.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Terra Innovatum Global S.R.L. (NASDAQ:NKLR) Trading 10.5% Higher - Here's What Happened

Terra Innovatum Global S.R.L. (NASDAQ:NKLR) Stock Price Up 10.5% - What's Next...

What is HC Wainwright's Estimate for NKLR Q4 Earnings?

Terra Innovatum Global S.R.L. (NASDAQ:NKLR - Free Report) - Equities research analysts at HC Wainwright issued their Q4 2025 earnings estimates for Terra Innovatum Global S.R.L. in a research report...

HC Wainwright Upgrades Terra Innovatum Global S.R.L. (NASDAQ:NKLR) to "Strong-Buy"

HC Wainwright raised Terra Innovatum Global S.R.L. to a "strong-buy" rating in a report on Tuesday...

Wall Street Analysts See a 178.19% Upside in Terra Innovatum Global N.V. (NKLR): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 178.2% in Terra Innovatum Global N.V. (NKLR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Terra Innovatum Global stock gained 8.6% in premarket trading on Wednesday, with retail investors debating its valuation compared to peers in the nuclear industry.Shares of rivals Oklo and NuScale Power rose 7.4% and 5.5%, respectively, as the U.S. Army unveiled plans to build small nuclear reactors at Army bases, in line with President Donald Trump's executive order directing the Army to operate a small nuclear reactor on a domestic base by September 2028.Terra Innovatum was listed on Nasdaq through a SPAC merger on Friday, joining a handful of companies that are betting on the novel technology.The firm, founded in Italy, is developing a small reactor that uses standard kinds of nuclear fuel, and management says it can operate continuously at full power for 15 years without refueling.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/NKLR">Terra Innovatum</a> was in the 'extremely bullish' territory at the time of writing.<figure class="image"><img style="aspect-ratio:792/95;" src="https://news.stocktwits-cdn.com/NKLR_Oct_15_JPG_9924cc6ecf.webp" alt="NKLR's Sentiment Meter and Message Volume as of 05:15 a.m. ET on Oct. 15, 2025 | Source: Stocktwits" width="792" height="95"><figcaption>NKLR's Sentiment Meter and Message Volume as of 05:15 a.m. ET on Oct. 15, 2025 | Source: Stocktwits</figcaption></figure>"Anyone who was part of the wild spac runs in 20-21 know[s] these have much more room to run if the market allows," one user said.<stembedurl>https://stocktwits.com/Puddlepiratetrading/message/632359498</stembedurl>&nbsp;Another user highlighted the importance of microreactors to meet A.I. demand while also noting that the company remains undervalued compared to its peers.<stembedurl>https://stocktwits.com/ClearCities/message/632352659</stembedurl>&nbsp;U.S. power demand is growing at the fastest pace since World War II, driven by the power-hungry data centers of companies like Meta, Amazon, and OpenAI. According to a report by Deloitte, power demand from AI data centers in the United States is expected to grow more than thirtyfold, reaching 123 gigawatts, up from 4 gigawatts in 2024.Oklo stock has risen more than eightfold this year, while NuScale stock has more than doubled amid growing optimism around the sector. However, some analysts have warned that most of the reactors are in the development stage, so the companies might find it difficult to justify the lofty valuation in the near term.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/gold-jumps-past-4-200-on-us-china-trade-concerns-fed-rate-hike-bets/ch6nqCKR3N5">Gold Jumps Past $4,200 On US-China Trade Concerns, Fed Rate Hike Bets</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cooling towers of a nuclear power plant in Oxford, UK.

Terra Innovatum Stock Pops Over 8% Premarket: Retail Traders Feel Nuclear Play Is Still 'Undervalued'

Shares of rivals Oklo and NuScale Power also surged as the U.S. Army unveiled plans to build small nuclear reactors at Army bases.

Equity

Red candles of the American S&P 500 index are seen in a chart on Trading View on the monitor of a computer in an office. Photo: Silas Stein/ (Photo by Silas Stein/picture alliance via Getty Images)

GSRT Stock In Spotlight After Terra Innovatum Merger Closes

The companies stated that the combined company will operate under the name Terra Innovatum Global N.V. and its ordinary shares will commence trading on the Nasdaq Global Market under the ticker symbol "NKLR" on October 10.

Terra Innovatum Global NV operates as a holding company that offers micro-reactor solutions. It engages in the development of nuclear micro modular solutions focused on clean energy. The firm's nuclear technology, the SOLO features a thermally-moderated, gas-cooled nuclear reactor core that operates with standard enrichment U235 and conventional Zircaloy-cladded UO2 fuel pellets. The company was founded on April 29, 2025 and is headquartered in Lucca, Italy.

NKLR
Terra Innovatum Global N.V. Ordinary shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NKLR News

NKLRTerra Innovatum Global N.V. Ordinary shares